This educational activity has been developed to provide medical oncologists, radiation oncologists, surgeons, urologists, and other healthcare professionals with a comprehensive overview of recent advances in the management of prostate and renal cell cancers.
At the conclusion of this activity, participants should be able to:
List therapeutic approaches to optimize outcomes for patients with advanced prostate cancer, including the importance of managing bone metastases
Compare and contrast traditional chemotherapies with novel chemotherapeutic agents in the management of patients with castration-resistant prostate cancer
Discuss the rationale and evaluate the clinical utility of biomarkers to guide the therapeutic decision-making process in patients with renal cell carcinoma
Describe current management strategies utilizing targeted therapies for patients with metastatic renal cell carcinoma based on prognostic risk stratification and toxicity-related issues
Past Events
Improving Outcomes in Prostate and Renal Cell Carcinomas 2010 - 29 May 2010, Moscone Center, San Francisco, California, United States (6145)
Improving Outcomes in Prostate and Renal Cell Carcinomas 2026
Important
Please, check "Improving Outcomes in Prostate and Renal Cell Carcinomas" official website for possible changes, before making any traveling arrangements
